Lejie Cao Selected Research

Stomatitis

1/2019

The Impact of Afatinib on Survival in Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lejie Cao Research Topics

Disease

20	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 09/2013
8	Neoplasms (Cancer) 02/2024 - 09/2013
6	Disease Progression 02/2024 - 12/2020
5	Neoplasm Metastasis (Metastasis) 11/2022 - 01/2020
3	Carcinoma (Carcinomatosis) 10/2022 - 10/2021
3	Exanthema (Rash) 11/2021 - 01/2019
2	Brain Neoplasms (Brain Tumor) 01/2022 - 01/2020
2	Pneumonia (Pneumonitis) 01/2022 - 01/2022
2	Lung Neoplasms (Lung Cancer) 10/2021 - 06/2004
1	Body Weight (Weight, Body) 10/2022
1	Heart Failure 01/2022
1	Septic Shock (Toxic Shock Syndrome) 01/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022
1	Adenocarcinoma of Lung 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022
1	Abdominal Pain (Pain, Abdominal) 01/2022
1	Multiple Organ Failure (MODS) 01/2022
1	Neutropenia 01/2022
1	Cough 10/2021
1	Dyspnea (Shortness of Breath) 10/2021
1	Chest Pain (Chest Pains) 10/2021
1	Tumor Lysis Syndrome 10/2021
1	Hypertension (High Blood Pressure) 01/2020
1	Diarrhea 01/2019
1	Stomatitis 01/2019
1	Breast Neoplasms (Breast Cancer) 03/2015
1	Plasma Cell Granuloma 06/2004
1	Lung Diseases (Lung Disease) 06/2004

Drug/Important Bio-Agent (IBA)

4	CrizotinibIBA 02/2024 - 01/2020
4	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2019
4	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2020
3	Anaplastic Lymphoma KinaseIBA 02/2024 - 01/2022
3	ensartinibIBA 02/2024 - 01/2020
3	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 01/2021
3	1- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazineIBA 10/2022 - 10/2021
2	Proteins (Proteins, Gene)FDA Link 02/2024 - 03/2015
2	PlatinumIBA 01/2023 - 01/2022
2	sugemalimabIBA 01/2023 - 01/2022
2	pembrolizumabIBA 01/2023 - 10/2021
2	Pemetrexed (MTA)FDA Link 01/2023 - 01/2021
2	LigandsIBA 01/2023 - 12/2022
2	camrelizumabIBA 12/2022 - 01/2021
2	Gefitinib (Iressa)FDA Link 11/2022 - 11/2022
2	aflutinibIBA 11/2022 - 11/2022
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 06/2004
2	Vorinostat FDA Link 03/2015 - 09/2013
2	ProteomeIBA 03/2015 - 09/2013
2	Histone Deacetylase InhibitorsIBA 03/2015 - 09/2013
1	toripalimabIBA 01/2024
1	atezolizumabIBA 01/2023
1	Cisplatin (Platino)FDA LinkGeneric 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Etoposide (VP 16)FDA LinkGeneric 01/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022
1	alectinibIBA 01/2022
1	EnzymesIBA 11/2021
1	Circulating Tumor DNAIBA 01/2021
1	osimertinibIBA 12/2020
1	Alanine Transaminase (SGPT)IBA 01/2020
1	HMPL-013IBA 01/2020
1	SteroidsIBA 01/2020
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2020
1	AfatinibIBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	Histone Deacetylases (Histone Deacetylase)IBA 03/2015
1	Lysine (L-Lysine)FDA Link 09/2013
1	Histones (Histone)IBA 09/2013
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 06/2004

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 01/2024 - 01/2020
7	Therapeutics 11/2022 - 09/2013
2	Immunotherapy 01/2024 - 01/2021